Pharma news – 4 June,2020
Remdesivir receives approval from the Indian government Gilead Sciences antiviral drug, Remdesivir has grabbed the attention of many countries for its ability to treat Covid-19. It was granted the emergency use authorization by the USFDA[1] in April,2020. The Japanese health regulators have also approved the use of Remdesivir in Covid-19 patients. On 1 June,2020 this […]